Facebook
Twitter
Telegram
Report an ErrorCancer Genetics, Inc. Financial Ratios 2011-2024 | CGIX
Annual Financial Ratios Cancer Genetics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | -1.2 | -0.3 | -2.0 | -2.2 | -1.3 | -4.3 | -6.3 | - | - |
P/S |
- | 1.1 | 0.2 | 1.4 | 1.3 | 1.5 | 7.0 | 11.9 | - | - |
EV/EBITDA |
0.3 | -2.8 | -0.6 | -2.3 | -2.0 | -0.7 | -2.9 | -4.3 | - | - |
PEG |
- | 0.34 | 0.05 | 0.2 | 0.17 | 0.07 | 0.2 | 0.15 | - | - |
P/B |
- | 1.1 | 1.0 | 1.5 | 1.3 | 0.8 | 2.1 | 1.7 | - | - |
P/CF |
- | -0.9 | -0.5 | -2.8 | -1.8 | -1.8 | -5.2 | -9.3 | - | - |
ROE % |
-201.03 | -90.83 | -299.51 | -78.01 | -61.67 | -61.13 | -48.17 | -27.21 | - | - |
ROA % |
-95.84 | -45.01 | -57.54 | -39.98 | -37.24 | -41.29 | -35.33 | -22.43 | - | - |
ROCE % |
-200.32 | -34.20 | -224.26 | -57.16 | -53.28 | -54.79 | -44.94 | -18.18 | - | - |
DSO |
49.4 | 79.1 | 93.5 | 137.3 | 158.5 | 134.0 | 180.0 | 90.5 | - | - |
DIO |
- | - | 28.0 | 37.0 | 3.1 | 3.4 | 12.1 | 14.7 | - | - |
DPO |
254.0 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency